Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2021-03-03 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Qualification certificate.pdf
Regulatory Filings Classification · 95% confidence The document is a Qualification Certificate signed by the CFO of PharmaCielo Ltd. It certifies the company's entitlement to file a short form prospectus under a specific National Instrument and mentions regulatory compliance details. The document is short (1130 characters) and primarily serves as a certification related to regulatory filing requirements. It does not contain financial statements, management discussion, or detailed report content. According to the Certification Rule, such officer certifications or attestations should be classified as Regulatory Filings (RNS).
2021-03-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing PharmaCielo's first commercial shipment of a new product, THC-free broad-spectrum distillate, to an existing customer. It includes details about the product, the company's business focus, and forward-looking statements. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a commercial shipment and product update rather than a financial report, management discussion, or regulatory filing. Therefore, it fits best into the category of a general regulatory announcement or corporate news release, which corresponds to Regulatory Filings (RNS).
2021-02-18 English
News release - English.pdf
Regulatory Filings
2021-02-02 English
News release - English.pdf
Regulatory Filings
2020-12-18 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic alliance between PharmaCielo Ltd. and AssuredTrans Inc. It discusses the business partnership, product quality assurance, and market expansion plans. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a business development rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general corporate announcement, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2020-12-11 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that PharmaCielo has received a loan of approximately CDN$3.0 million from Banco Agrario, a Colombian state-owned bank. The content focuses on the terms of the loan, the company's financial position, and forward-looking statements about the company's business prospects. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an update on a financing activity, specifically a non-dilutive loan, which fits the category of Capital/Financing Update (CAP). The document length is about 6922 characters, which is sufficient for a detailed announcement but does not constitute a full financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-12-07 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.